Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Exchange Rate Effect (2018 - 2025)

X4 Pharmaceuticals' Exchange Rate Effect history spans 8 years, with the latest figure at $3000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 101.23% year-over-year to $3000.0; the TTM value through Dec 2025 reached $213000.0, up 236.54%, while the annual FY2025 figure was $213000.0, 236.54% up from the prior year.
  • Exchange Rate Effect reached $3000.0 in Q4 2025 per XFOR's latest filing, up from -$1000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $363000.0 in Q4 2022 to a low of -$244000.0 in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$13400.0, with a median of -$12000.0 recorded in 2023.
  • Peak YoY movement for Exchange Rate Effect: crashed 605.0% in 2022, then skyrocketed 872.22% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$116000.0 in 2021, then skyrocketed by 412.93% to $363000.0 in 2022, then crashed by 65.01% to $127000.0 in 2023, then crashed by 292.13% to -$244000.0 in 2024, then surged by 101.23% to $3000.0 in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Exchange Rate Effect are $3000.0 (Q4 2025), -$1000.0 (Q3 2025), and $139000.0 (Q2 2025).